Background Chronic stress may affect morbidity and mortality through neuroendocrine changes, and the ratio of cortisol to sex steroid hormones has been suggested as a biomarker of stress. We aim to address a relation between the ratio of cortisol to estrogens (C/E) and risk of ischaemic heart disease (IHD), hormone-dependent cancers and all-cause mortality among postmenopausal women.
Introduction
Psychological stress is a rising public health problem and potential health consequences of stress are of interest to researchers and the public alike. The majority of studies in this area has addressed a potential relation between stress and cardiovascular disease, which is both biologically plausible and empirically supported in a range of observational studies. [1] [2] [3] [4] However, most of these studies have used questionnaire-based measures of stress, and it has been questioned whether the observed associations between stress and cardiovascular disease in observational epidemiologic studies are causal or rather a result of reporting bias. 5, 6 Neuroendocrine changes are a central component of the stress response and the use of biomarkers of stress has been suggested as an alternative strategy. There have been few methodologically sound prospective studies in this area, principally due to difficulties in applying biomarkers in a large population sample. Chronic stress may result in a persistent activation of stress hormones such as cortisol, which may eventually lead to an impairment of estrogen synthesis. 7, 8 A high ratio of cortisol to sex steroid hormones has therefore recently been suggested to be indicative of a chronic physiologic stress response. 9, 10 A biological measure of chronic stress may be less prone to confounding from other personal factors than the questionnairebased measure of perceived stress. The ratio of cortisol to testosterone (C/T) has recently been shown to increase the risk of ischaemic heart disease (IHD) in men, 9, 10 but the association in women remains to be studied.
The role of stress in the aetiology of hormonedependent cancers has been an area of emerging interest, in part because of the ability of stress to alter endogenous levels of estrogens. 7, 8 We have previously reported an inverse dose-response association between self-reported stress and incidence of primary breast cancer, 11 but the relation between stress and cancer remains controversial. 12 The relation between a biological measure of chronic stress and hormone-dependent cancers has not previously been addressed. We aim to address a relation between chronic stress measured as the ratio of cortisol to estrogens (C/E) and risk of IHD, hormone-dependent cancers (breast, ovarian and endometrial cancer) and all-cause mortality among a population sample of postmenopausal women.
Methods

Study population
The Copenhagen City Heart Study was initiated in 1976. An age-stratified sample of 19 698 men and women were randomly drawn from the Central Population Registry and invited to participate in the study. In 1981-83, the study population was supplemented with 500 men and women and additional study examinations were performed. The response rate at this examination was 70%. The 12 698 participants in the second examination counted 5297 postmenopausal women and all participants gave informed consent. A detailed description of the Copenhagen City Heart Study has previously been published elsewhere. 7 Hormone levels were assayed in a random sample of postmenopausal women (n ¼ 1150) drawn from the base population in 1981-83 as well as among all women who developed hormone-dependent cancer between baseline and 31 December 2000 (260 breast cancers, 59 ovarian cancers, 75 endometrial cancers) in a case-cohort design ( Figure 1 13, 14 The assay used for determination of cortisol in serum was a competitive RIA (Spectria Cortisol Coated Tube RIA; Orion Diagnostica, Espoo, Finland). The method for determination of cortisol has previously been described for use in saliva. 15 A method evaluation of certified reference material in water showed a bias of the method recovery was 88.8% (95% CI 79.1-98.6%). LOD was 4.7 nmol/l. Between-run coefficients of variation were 9.5% at 69 nmol/l and 11.6% at 236 nmol/l for cortisol in serum, and 6.9% at 199 pmol/l and 10.4% at 649 pmol/l for 17b-estradiol in serum. Westgard control charts were used to document that the analytical method remained in analytical and statistical control; that is, the trueness and the precision of the analytical methods remained stable.
Follow-up
First hospital admissions for IHD (ICD-codes 410-414 and I20-I25) and myocardial infarction (ICD codes 410 and I21-22) were identified from the Danish Hospital Register, which was instituted on 1 January 1977. The Register contains individual information on all hospital admissions for medical conditions in Denmark. For each patient the information is computerized and kept even after the patients have died, including codes for hospital department, dates of admission and discharge, diagnosis (ICD-8 until 1993 and ICD-10 afterwards) and a unique 10-digit personal identification number. The latter includes information on date of birth, sex and a control digit, and it permits exact linkage between information from administrative and research registries in Denmark. The register is updated until 9 July 2007. Cases of hormone-dependent cancers (breast cancer: ICD-code 170, endometrial cancer: ICD-7 code 172, ovarian cancer: ICD-7 code 175) were obtained through linkage to the Danish National Cancer Registry, which contains data on all cancer diagnoses in Denmark. We included information from this register up until 31 December 2000. The vital status of the study population was followed in the Central Death Registry, which had updated information until 11 August 2007. The participants were followed from the date of second examination until date of first diagnosis of the disease in question (i.e. IHD, myocardial infarction or hormone-dependent cancer), death, emigration or end of follow-up. Less than 0.1% of the women were lost to follow-up due to emigration.
Statistical analyses
Sex steroid hormones and cortisol are known to have a circadian rhythm, which makes it important to control for the time of day at which the blood is drawn. We graphically examined the circadian pattern of estradiol and cortisol and we included both a linear and quadratic term of time for blood draw to adjust for the observed patterns. The relations between cortisol/estrogen (C/E) ratio and IHD, myocardial infarction and all-cause mortality were assessed in a prospective study design based on a random sample of postmenopausal women drawn from the base population in 1981-83, whereas a case-cohort design was applied to study the relation between the C/E ratio and hormone-dependent cancer risk. Estimation of hazard ratios (HRs) in the case-cohort analysis was based on a Kalbfleisch and Lawless casecohort analysis with robust estimators of variance. 16 The case-cohort analysis is based on a case group that consists of all women who have developed hormone-dependent cancer and a control group that consists of the random sample of women described above. The control group is weighted in order to represent the total study population and a robust estimator of variance is applied to take the oversampling of cases into account. First, the associations between C/E ratio and disease risks were assessed in a Cox regression model adjusted for age and time of blood draw.
Subsequently, a multivariable Cox regression model was fitted to adjust for potential confounding from age, time of blood draw, marital status, education, tobacco smoking, alcohol intake, physical activity in leisure time and body mass index. When studying specific diseases such as IHD, myocardial infarction or stroke, women with an existing diagnosis of the disease in question at baseline were excluded from the analyses. Although estrogen is the most relevant sex steroid hormone in women, we also addressed the relation between the C/T ratio and health outcomes in a supplementary analysis to enable direct comparison with previous studies of this relation. 9, 10 Furthermore, we restricted the study population to only include the 40% of the sample who had blood sampled before 9 a.m. to address whether diurnal variations in cortisol and hormone levels had affected our results.
Ethical approval
The Danish ethics committee for the City of Copenhagen and Frederiksberg approved the study (#01-144/01). All participants gave written informed consent.
Results
Baseline characteristics
The median cortisol level was 240 nmol/l with respective 10th and 90th percentiles of 136 and 390 nmol/l.
Cortisol showed a circadian pattern with declining values over time during the morning, after which it levelled off. The median 17b-estradiol value was 24.8 pmol/l with 10th and 90th percentiles of 7.4 and 122.5 pmol/l, respectively. There was no clear circadian pattern in blood concentration of 17b-estradiol. Table 1 shows how mean cortisol and estrogen levels vary according to quartiles of the C/E ratio. The mean age at baseline was 63 years, and the C/E ratio was associated with higher age. Although there were no trends over quartiles, the C/E ratio was associated with several of the potential confounders, especially alcohol consumption, physical activity and body mass index. The C/E ratio showed no clear association with perceived stress (P ¼ 0.23). Apart from diastolic blood pressure, the C/E ratio was not associated with the factors that could be conceptualized as potential intermediary variables, namely cholesterol, high-density lipoprotein-cholesterol, systolic blood pressure, antihypertensive treatment and diabetes.
Cortisol, sex steroid hormones and disease risk Over the follow-up period, 233 women were admitted to the hospital with a diagnosis of first-time IHD, 98 suffered from myocardial infarction and 599 women died. The C/E ratio appeared to be associated with a modestly higher risk of IHD (highest vs lowest quartile: HR ¼ 1.23; 95% CI 0.83-1.81) and myocardial infarction (1.44; 0.79-2.62) but the risk estimates were unstable and there were no clear trends in the (Table 2) . Also, there was no clear association between the C/E ratio and all-cause mortality.
In the case-cohort study, 242 cases of hormonedependent cancers (158 breast cancer cases) were included. Despite unstable risk estimates, the C/E ratio seemed to be associated with a slightly lower risk of hormone-dependent cancers combined (highest vs lowest quartile: HR ¼ 0.69; 95% CI 0.45-1.08) but not with breast cancer alone (0.87; 0.50-1.51), and again there were no clear trends. Adjustment for potential confounders did not lead to major changes in the risk estimates. We repeated the above analyses with cortisol and estrogen quartiles separately (Tables 3 and 4) . Cortisol was not associated with any of the disease outcomes or all-cause mortality. Higher levels of estrogens were associated with higher risks of hormone-dependent cancers (P trend ¼ 0.03). Women in the high quartile of estrogen compared with the low quartile had an HR of 1.59 (95% CI 1.02-2.48) for developing hormone-dependent cancer during follow-up. Estrogen quartiles were not independently associated with breast cancer, IHD, myocardial infarction or all-cause mortality. In supplementary analyses, we found no relation between the C/T ratio and any of the disease outcomes except a lower risk of breast cancer associated with a higher C/T ratio, but again with no clear trend over quartiles (P trend ¼ 0.19) (data not shown). Also, restricting the analyses to only include those with morning blood samples did not affect the results markedly.
Discussion
In this prospective study of postmenopausal women, the C/E ratio showed no clear associations with IHD, hormone-dependent cancers and all-cause mortality and we can thereby not replicate the robust findings of a relation between the C/T ratio and coronary heart disease previously reported in men. 9, 10 We found no clear indications of a relation between either the C/E ratio or the C/T ratio and IHD in the present study, which contrasts with the robust findings of dose-response relations between C/T ratio and coronary heart disease previously reported by Smith and colleagues. 9 Although Smith et al. reported strong positive associations of C/T ratio with components of the insulin resistance syndrome in men, we found no consistent associations between C/E ratio and cardiac risk factors such as cholesterol, HDL-cholesterol and blood pressure in postmenopausal women. Whether this is a result of sex-specific effects of the cortisol to sex steroid hormones ratio on IHD or a question concerning the validity of the measure remains undetermined. Women in the highest C/E-ratio quartile seemed to have lower risks of developing hormone-dependent cancers, an association most likely driven by higher mean estrogen levels in the higher quartiles of the C/E ratio. When using an established risk factor for breast cancer in the ratio measure, namely plasma levels of estrogens, 17 the observed association is as expected.
Strengths and weaknesses
To our knowledge, this is the first prospective population-based study to address the relation between C/E ratio and morbidity and mortality in women. Information on plasma cortisol and estrogen levels in a large subset of postmenopausal women from the Copenhagen City Heart Study allowed us to evaluate this relation. Linkage of civil registry numbers to nationwide population-based registers enabled identification of first-time hospital admission for IHD and hormone-dependent cancers as well as all-cause mortality and allowed for nearly complete long-term follow-up. A case-cohort study was applied as an efficient design to estimate the HR of hormonedependent cancer in the whole cohort without obtaining information on every person included in the cohort. 18 One may question whether the C/E ratio is in fact a reasonable measure of chronic stress or even a possible intermediate variable on the pathway from stress to disease. We observed no clear associations between a questionnaire-based measure of perceived stress and C/E ratio quartiles in the present study. In a similar vein, Smith et al. found no strong association between the C/T ratio and a questionnaire-based measure of stress in men. 9 Assuming they are measures of the same underlying concept of chronic stress, the lack of associations is of concern. The argument for using C/E ratio as a biomarker for stress is based on the idea that cortisol impairs normal secretion of sex steroid hormone (estrogens in women and testosterone in men), but the interrelation between glucocorticoids and estrogens may be much more complex. For example, estrogens have been suggested to affect stress responsiveness and thereby be a potential effect modifier of the stress response. 19 Also, life-style factors such as physical activity, alcohol consumption and body mass index are known to affect estrogen levels as well as morbidity and mortality 20 and one may be concerned about confounding from such factors when using C/E ratio as a biomarker of stress.
Lack of statistical power may have blurred the results for infrequent events such as myocardial infarction, and even though there were no clear dose-response trends we cannot exclude the possibility that the C/E ratio would have been associated with, for example, myocardial infarction in a larger study sample.
Cortisol and estradiol have intrinsic biological variability, 21 which may have decreased the reliability of a single measurement of hormonal levels and may have blurred associations between the C/E ratio and disease risks. Sampling at a specific time or several samples from each individual would have been preferable. On the other hand, such an approach would have been much more time consuming and expensive and would probably not have been feasible in a large population study such as the one at hand. Also, a previous study has found correlations for 2-3 years between replicate measures of plasma estrogens levels to be quite high, making a single measurement relatively reliable. 22 The blood samples were first assayed 420 years after collection. During this period they were stored at -208C. Steroid hormones, in general, seem to be relatively stable over time at this temperature 23 and we do not expect this time span to have seriously distorted our internal comparisons of hormone levels between risk-factor categories. However, due to the long-term storing, a higher proportion of the sex steroid hormones may be in an unbound form compared with other studies. 24 We used register information on first-hospital admission for IHD and hormone-dependent cancers. The validity and coverage of register information on more chronic diagnoses such as IHD may be of concern and could be a possible explanation of the unclear results for IHD in the present study. However, the results for myocardial infarction-a more acute and specific diagnosis-were very similar to those for IHD, which contradicts the argument.
In conclusion, the C/E ratio is not associated with IHD, hormone-dependent cancer or all-cause mortality in postmenopausal women in the present study and we cannot replicate the robust findings of a relation between the C/T ratio and coronary heart disease previously observed in men. Also, the C/E ratio is not associated with perceived stress and whether the C/E ratio is a reasonable biomarker of chronic stress or merely a marker of dysfunctions in the neuroendocrine system is debatable.
